Acknowledgements We are grateful to Shinji Sakai, Shinji Deguchi, Kana Furukawa for animal care
If trial results are positive, Eli Lilly could submit for FDA approval as early as 2025-2026, with potential commercial availability following approval
Simply put, these stages are before or after the permanent pause of menstruation
Outside primary metabolic indications, these mechanisms are also of interest for cardiometabolic risk reduction (such as waist circumference, triglycerides, and blood pressure) and for appetite control during lifestyle-based weight loss plans
free-drug occupancy method (albumin Kd 1.86 uM, free fraction 0.29%): Willard JCI Insight 2020
Some begin a tapering plan toward a lower maintenance dose